Calcium receptor modulating agents

   
   

The compounds of the invention are represented by the following general structure ##STR1##

or a pharmaceutically acceptable salt thereof, and compositions containing them, wherein the variables are defined herein, and their use to reduce or inhibit PTH secretion, including methods for reducing or inhibiting PTH secretion and methods for treatment or prophylaxis of diseases associated with bone disorders, such as osteoporosis, or associated with excessive secretion of PTH, such as hyperparathyroidism. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

 
Web www.patentalert.com

< Proteins and methods for producing the proteins

< Topical drug preparations

> Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytes

> Apparatus with weeping tip and method of use

~ 00189